Arbutus Biopharma Corporation is a biopharmaceutical company that develops and commercializes a range of therapeutic products for the treatment of chronic hepatitis B virus (HBV) infection. The company's product pipeline includes a range of drug candidates in various stages of development, including both clinical and preclinical programs. Arbutus Biopharma Corporation was founded in 1992 and is headquartered in Burnaby, British Columbia, Canada.